Durvalumab for Hepatocellular Carcinoma User Reviews
Brand names: Imfinzi
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Hepatocellular Carcinoma
Care guides
Symptoms and treatments
More about durvalumab
- Check interactions
- Compare alternatives
- Reviews (8)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"Have had two infusions, and so far, so good—no side effects except feeling tired on the second day after infusion. Other than that one day, I feel fine. I have my next MRI in October to check for more cancer. Hopefully, Imfinzi is working, and I will have no return spots. Time will tell."